2019³â ´ëÇÑÆó¾ÏÇÐȸ Ãß°èÇмú´ëȸ : 2019-11-21±³À°ÀÏÀÚ : 2019-11-21
±³À°Àå¼Ò : Àá½Ç ·Ôµ¥È£ÅÚ Å©¸®½ºÅ»·ë
±³À°ÁÖÁ¦ :
2019³â ´ëÇÑÆó¾ÏÇÐȸ Ãß°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540
À̸ÞÀÏ :
kalc@lungca.or.kr ±³À°Á¾·ù : ³»°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 15 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í »çÀüµî·Ï(Àü¹®ÀÇ): 5¸¸¿ø ÇöÀåµî·Ï(Àü¹®ÀÇ): 7¸¸¿ø ÇöÀåµî·Ï(Àü°øÀÇ/Çлý/ÀüÀÓÀÇ/°£È£»ç/±âŸ): 5¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2 09:00~09:25 Tracing genomic rearrangements in the mutational history of lung adenocarcinomas ÁÖ¿µ¼®(KAIST)
±³À°½Ã°£ 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2 09:25~09:50 Mutation signatures in public cancer genomes ±èŹÎ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2 09:50~10:15 Air pollution and epigenetic alteration ±è¿ìÁø(°¿øÀÇ´ë)
±³À°½Ã°£ 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2 10:15~10:40 Air Pollution and Lung Caner À±Çü±Ô(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 3 09:00~09:25 An introduction to Radiomics (I): Basics ±èÇüÁø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 3 09:25~09:50 Radiomics in lung cancer from basics to advanced: A pragmatic approach for real-world application ÀÌÈ£¿¬(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 3 09:50~10:15 AI in medical imaging: current issues and challenges ±èÈÖ¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 3 10:15~10:40 AI applications in lung cancer ÀÌ»ó¹Î(¿ï»êÀÇ´ë)
ÈÞ½Ä 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 10:40~11:10 ÈÞ½Ä ()
±³À°½Ã°£ 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 11:10~11:50 Molecular characteristics of Malignant Pleural Mesothelioma Raphael Bueno(Brigham and Women)
Åä·Ð 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 11:50~12:00 Q & A Raphael Bueno(Brigham and Women)
½Ä»ç 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 12:00~12:40 Luncheon Symposium I ¾È¸íÁÖ(¼º±Õ°üÀÇ´ë)
ÈÞ½Ä 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 12:40~13:10 ÈÞ½Ä ()
±³À°½Ã°£ 11-21 Crystal 1 13:10~13:35 Immunotherapy for challenging patients ÃÖâ¹Î(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 1 13:35~14:00 Re-emerging role of anti-angiogenic inhibitors in immunotherapy era ±è¹Ì¼Ò(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 1 14:00~14:25 Can chemoimmunotherapy or dual immunotherapy challenge immuno-monotherapy? ÀÌ°æ¿ø(°æ»óÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 1 14:25~14:50 Immune checkpoint inhibitor for operable NSCLC ¹Ú»ó°ï(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 2 13:10~13:35 SBRT for centrally located lung cancer ÀÓäȫ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 2 13:35~14:00 Current status and perspectives of radiation therapy in the era of immunotherapy À̱ÔÂù(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 2 14:00~14:25 Patient selection for proton therapy in lung cancer ¼¾ç±Ç(±¹¸³¾Ï¼¾Å¸)
±³À°½Ã°£ 11-21 Crystal 2 14:25~14:50 Application of liquid biopsy in lung cancer patients receiving radiotherapy ³ëÀç¸í(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-21 »çÆÄÀ̾î b·ë 13:10~13:35 Basic concepts and clinical applications of Electromagnetic Navigation Bronchoscopy Áö¿øÁØ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-21 »çÆÄÀ̾î b·ë 13:35~14:00 Hands-on Session1. Electromagentic Navigation Bronchoscopy À±È£ÀÏ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-21 »çÆÄÀ̾î b·ë 14:00~14:25 Hands-on Session2. Electromagentic Navigation Bronchoscopy ÀÌ°æÁ¾(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-21 »çÆÄÀ̾î b·ë 14:25~14:50 Hands-on Session3. Electromagentic Navigation Bronchoscopy ¹Úµ¿ÀÏ(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 1 14:50~15:50 Oral Presentation I. ³ª±¹ÁÖ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 2 14:50~15:50 Oral Presentation II ÀÌÀçö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 3 14:50~15:10 Surgery for Malignant Pleural Mesothelioma Raphael Bueno(Brigham and Women)
±³À°½Ã°£ 11-21 Crystal 3 15:10~15:30 Radiotherapy for Malignant Pleural Mesothelioma ±è¿¬½Ç(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 3 15:30~15:50 Systemic Treatment for Malignant Pleural Mesothelioma ¾ÈÈñ°æ(°¡ÃµÀÇ´ë)
ÈÞ½Ä 11-21 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 15:50~16:10 ÈÞ½Ä ()
±³À°½Ã°£ 11-21 Crystal 1 16:10~16:35 Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC À̼¼ÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 1 16:35~17:00 Characteristics of anti-PD-1-unresponsive CD8+ T cells in NSCLC ½ÅÀÇö(KAIST)
±³À°½Ã°£ 11-21 Crystal 1 17:00~17:25 Tumor microenvironment and immune checkpoint blockade in NSCLC ÀüÀ±°æ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 1 17:25~17:50 Regulation and function of a novel IL-17-producing T cell population in tumor Á¤¿¬¼®(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-21 Crystal 2,3 16:10~16:35 Genomic landscape of SCLC ¹ÌÁ¤()
±³À°½Ã°£ 11-21 Crystal 2,3 16:35~17:00 Immunotherapy for SCLC ¹ÌÁ¤()
±³À°½Ã°£ 11-21 Crystal 2,3 17:00~17:25 Role of surgery in LD-SCLC Yasuhiro Tsutani(Hiroshima University)
±³À°½Ã°£ 11-21 Crystal 2,3 17:25~17:50 PCI issue Takashi Seto(National Kyushu Cancer)